$FTRE

$24.43 +$0.60 (2.52%) Close

$FTRE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$FTRE Management Team

Mr. Anshul Thakrala

President

Chief Executive Officer

Director

Age -

Compensation -

Sex Male

Ms. Hima Inguva

Investor Relations

Age -

Compensation -

Sex Female

Mr. Peter Neupert

Chairman of the Board

Age 69

Compensation $320.0K USD

Sex Male

Ms. Jill Mcconnell

Chief Financial Officer

Age 51

Compensation $1.324M USD

Sex Female

Mr. Mark Morais

Chief Operating Officer and President - Clinical Services

Age 49

Compensation $1.324M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Anshul Thakrala President Chief Executive Officer Director	-	-	Male
Ms. Hima Inguva Investor Relations	-	-	Female
Mr. Peter Neupert Chairman of the Board	69	$320.0K USD	Male
Ms. Jill Mcconnell Chief Financial Officer	51	$1.324M USD	Female
Mr. Mark Morais Chief Operating Officer and President - Clinical Services	49	$1.324M USD	Male

Board of Directors

From the proxy statement filed Apr 27, 2026

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

2.1 years

from year joined

CEO also chairs the board

Peter M. Neupert

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Peter M. Neupert Board chair	70	2023 3 years	Not stated	None stated	Labcorp	Not stated
Anshul Thakral CEO	48	2025 1 year	Not stated	None stated	Orsini Specialty Pharmacy	Paid as CEO
William J. Sharbaugh	63	2025 1 year	Not stated	None stated	Ora Clinical	$22,500
Amrit Ray	53	2023 3 years	Not stated	None stated	Ultragenyx Pharmaceutical Inc.	Not stated
Erin L. Russell	52	2025 1 year	Not stated	Audit	eHealth, Inc.	Not stated
Machelle Sanders	62	2024 2 years	Not stated	None stated	BioCryst Pharmaceuticals, Inc.	Not stated
Edward Pesicka	59	2023 3 years	Not stated	Audit	Owens & Minor, Inc.	Not stated
David Smith	60	2023 3 years	Not stated	Audit · Chair	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 27, 2026

Labcorp

Amount not stated

Separation and Distribution Agreement and other agreements (Transition Services, Tax Matters, Employee Matters) governing ongoing relationships after the Spin

With Labcorp Open in proxy

Comments

Company Executives

$FTRE Management Team

Mr. Anshul Thakrala

Ms. Hima Inguva

Mr. Peter Neupert

Ms. Jill Mcconnell

Mr. Mark Morais

Board of Directors

Related-party transactions